Amylyx Pharmaceuticals (AMLX)
29.13
+0.10 (0.34%)
Upcoming Events
Latest Headlines
U.S. biotech SMids: Q3 earnings preview
October 18, 2026 8:00 PM - StreetInsider
Form 4 Amylyx Pharmaceuticals, For: Oct 05 Filed by: MILNE GEORGE M JR
October 7, 2026 4:00 PM - SEC Filing
Amylyx to present Phase 3 avexitide trial data at ObesityWeek 2026
October 6, 2026 8:01 AM - StreetInsider
Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
October 6, 2026 8:00 AM - BizWire
Form 144 Amylyx Pharmaceuticals, Filed by: MILNE GEORGE M JR
October 5, 2026 4:38 PM - SEC Filing
Amylyx Pharmaceuticals (AMLX) Reiterated at Buy by Stifel on Ph3 Data for Avexitide
October 1, 2026 7:24 AM - StreetInsider
Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
September 23, 2026 9:00 AM - BizWire
Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Bedrosian Camille L
September 14, 2026 4:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: FRATES JAMES M
September 14, 2026 4:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Klee Justin B.
September 14, 2026 4:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Mazzariello Gina
September 14, 2026 4:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Cohen Joshua B
September 14, 2026 4:00 PM - SEC Filing
Form 144 Amylyx Pharmaceuticals, Filed by: Cohen Joshua B
September 11, 2026 4:01 PM - SEC Filing
Form 144 Amylyx Pharmaceuticals, Filed by: Klee Justin B.
September 11, 2026 4:01 PM - SEC Filing
Form 144 Amylyx Pharmaceuticals, Filed by: Bedrosian Camille L
September 11, 2026 4:01 PM - SEC Filing
Form 144 Amylyx Pharmaceuticals, Filed by: Mazzariello Gina
September 11, 2026 4:01 PM - SEC Filing
Form 144 Amylyx Pharmaceuticals, Filed by: FRATES JAMES M
September 11, 2026 4:01 PM - SEC Filing
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $57 at Guggenheim
August 27, 2026 6:55 AM - StreetInsider
Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Klee Justin B.
August 20, 2026 9:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: FRATES JAMES M
August 20, 2026 9:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Mazzariello Gina
August 20, 2026 9:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Cohen Joshua B
August 20, 2026 9:00 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Aug 18 Filed by: Bedrosian Camille L
August 20, 2026 9:00 PM - SEC Filing
Form 8-K Amylyx Pharmaceuticals, For: Aug 19
August 20, 2026 5:28 PM - SEC Filing
Form 424B5 Amylyx Pharmaceuticals,
August 20, 2026 5:28 PM - SEC Filing
Amylyx prices $500M stock offering at $35.50 per share
August 19, 2026 11:06 PM - StreetInsider
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
August 19, 2026 11:06 PM - BizWire
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
August 19, 2026 7:26 AM - StreetInsider
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird
August 19, 2026 6:37 AM - StreetInsider
Form 424B5 Amylyx Pharmaceuticals,
August 18, 2026 5:18 PM - SEC Filing
Amylyx Pharmaceuticals launches $350M common stock offering
August 18, 2026 4:01 PM - StreetInsider
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
August 18, 2026 4:01 PM - BizWire
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
August 18, 2026 3:40 PM - StreetInsider
Amylyx Pharmaceuticals (AMLX) 19K contracts trade
August 18, 2026 1:51 PM - StreetInsider
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
August 18, 2026 12:28 PM - StreetInsider
Form 8-K Amylyx Pharmaceuticals, For: Aug 18
August 18, 2026 9:04 AM - SEC Filing
Form 8-K Amylyx Pharmaceuticals, For: Aug 18
August 18, 2026 7:10 AM - SEC Filing
Amylyx's avexitide cuts hypoglycemia events 55% in Phase 3 trial
August 18, 2026 7:00 AM - StreetInsider
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
August 18, 2026 7:00 AM - BizWire
Amylyx to release Phase 3 avexitide trial results Aug. 18
August 17, 2026 4:01 PM - StreetInsider
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026
August 17, 2026 4:01 PM - BizWire
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Mizuho
August 17, 2026 6:38 AM - StreetInsider
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $28 at Baird
August 6, 2026 3:50 PM - StreetInsider
Form 10-Q Amylyx Pharmaceuticals, For: Jun 30
August 6, 2026 7:04 AM - SEC Filing
Form 8-K Amylyx Pharmaceuticals, For: Aug 06
August 6, 2026 7:02 AM - SEC Filing
Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 4c
August 6, 2026 7:01 AM - StreetInsider
Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 6, 2026 7:00 AM - BizWire
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
August 3, 2026 9:00 AM - BizWire
Full Article List
